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The environment plays an important role in
health and human development. Acute effects
from exposure to environmental contami-
nants, such as pesticide poisoning, are well
recognized, but the environmental link to
most chronic diseases remains unclear.
Researchers have linked exposure to specific
environmental hazards with a health effect,
such as benzene and leukemia. Other associa-
tions are suspect, such as exposure to mixtures
of drinking water disinfection by-products
and bladder cancer. In other cases, linkages
between environmental agents, individually or
as mixtures, and health outcomes lack epi-
demiologic evidence and are postulated from
laboratory animal studies. The Pew
Environmental Health Commission (2000)
calls the lack of information linking environ-
mental hazards and chronic disease the “envi-
ronmental health gap.” To address this gap,
the Centers for Disease Control and
Prevention (CDC) established the National
Environmental Public Health Tracking
Network (EPHTN; CDC 2003a), which is
developing the infrastructure, resources, and
methods for assembling and using available
environmental hazard, exposure, and health
outcome data (HOD). This initiative presents
great methodologic challenges such as using
existing data in new ways and for purposes
other than for which they were collected;
expanding the limited guidance for using
available statistical methods to analyze and
link data; and closing gaps in methodology for
linking disparate data sets. Despite the
challenges, great opportunities exist to forge
partnerships to make data more available,
develop standards to facilitate data exchange,
and analyze data to describe the impact of
environmental hazards on human health.
However, without defining the appropriate
rules for data linkage, indiscriminate linking
may lead to erroneous conclusions. This high-
lights the need to understand each data set,
articulate the uses and limits of each data set,
and standardize methods for using the data.
Fundamental Premise for
Linking Data
Fundamental questions must be asked before
linking different types of data. For example:
Is there a scientific basis for connecting the
data sets? Are the data to be linked adequate
and appropriate for addressing the issue? A
useful framework for examining these ques-
tions has been presented by Thacker et al.
(1996) in their description of a seven-step
“hazard-exposure-outcome” axis that outlines
the process of how an environmental hazard
produces an adverse health outcome. In this
process, Thacker et al. elucidate the steps
whereby an environmental agent moves
through the environment (hazard), enters a
person (exposure), and produces an effect
(health outcome). Associations made between
hazard and health are not conclusive without
considering actual exposure, although expo-
sure is often estimated from hazard data.
Thacker et al. (1996) further describe the
type of public health surveillance associated
with each of these steps: a) hazard surveillance
tracks the presence of an agent in the environ-
ment and environmental pathways (e.g., air,
water) leading to the routes of exposure;
b) exposure surveillance monitors exposure of
the host to the agent (biomarkers of expo-
sure), the distribution to a target tissue, and
production of effects (biomarkers of effect);
c) outcome surveillance follows clinically
observable disease (Thacker et al. 1996). The
linkage of two or more types of data provides
a powerful tool but only if the steps in the
process are taken into account.
Data Issues and Implications 
of Data Inadequacies
Before examining statistical methods for
linking various types of data, it is necessary to
examine data sources that are available for
tracking and linking hazards, exposure, and
health effects. Fundamental factors that pro-
vide conﬁdence in the results of data linkage
are data quality, appropriate use of the data,
and consideration of data limitations. The
quality of hazard, exposure, and HOD are
diverse, and the uses and limitations of data
outside of its original purpose are not yet well
deﬁned.
Hazard data. Hazard data provide infor-
mation about the presence and quantity of
contaminants in environmental media. A haz-
ard has the potential for harmful effects, but
its presence alone may not be sufficient to
produce an adverse effect in a population.
Most environmental data collection by
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http://dx.doi.org/ [Online 3 August 2004]federal and state environmental agencies is
mandated by legislation such as the Clean Air
Act (1970), Clean Water Act (1977), and
Safe Drinking Water Act (1974), and data are
used for regulatory purposes. Examples of
environmental data include the Toxic Release
Inventory (TRI; http://www.epa.gov/tri/),
criteria air pollutant data (ozone, sulfur diox-
ide, particulate matter), pesticide exposures,
and the Safe Drinking Water Information
System (SDWIS; http://www.epa.gov/enviro/
html/sdwis/). Data analysis is often limited to
comparison of each data point with an envi-
ronmental standard or guideline, and regula-
tory action is triggered if the data point
exceeds the standard. Standards are not avail-
able for all environmental contaminants, and
those that do exist are extrapolated primarily
from toxicologic studies. Standards are devel-
oped for regulatory purposes and include
uncertainty and safety factors that are meant
to be protective of public health; exceeding
the standard does not predict health out-
comes in the population.
Hazard data alone are not measures of
individual exposure; in some cases, certain
types of hazard data; for example, monitoring
contaminants in drinking water, may con-
tribute to the characterization of population
exposure. Table 1 lists limitations in the use
of hazard data for EPHTN.
Exposure data. Exposure data are the
essential link between environmental hazards
and health outcomes. Optimally, exposure
data include biomarkers such as a compound
or its metabolite(s) in a biologic sample (e.g.,
blood, urine, hair, fat). Levels of agents in
blood or urine are not necessarily propor-
tional to environmental concentrations.
Additionally, factors such as exposure level,
route of exposure, frequency and duration of
exposure, baseline health status, behavioral
factors, and genetics influence the internal
dose of the compound in an individual.
Exposure data represent the largest data
gap for EPHTN. Ideally, exposure data
would be available at the individual level, but
very few of these types exist. Childhood lead
levels are one of the few nationwide exposure
data sets. The CDC initiative to monitor
exposure of the general population to 116
environmental chemicals through biomoni-
toring as a part of the National Health and
Nutrition Examination Survey (NHANES) is
providing essential baseline exposure data
(CDC 2003b). However, there are no other
systematic biomonitoring programs that pro-
vide nationwide exposure data. Data from
sporadic, single-event biomonitoring that
occurs in response to specific incidents or
investigations are not widely available.
Another limitation is the rapid metabolism
and clearance of many compounds of
concern. Because of the limited availability of
exposure data, these parameters are often
estimated rather than measured. Exposure
modeling and assessments, as used in regula-
tory risk assessment, are meant to be protec-
tive of public health and therefore use
conservative assumptions that overestimate
actual exposure (e.g., consumption of 2 L/day
of water for 70 years; U.S. Environmental
Protection Agency 1989). Multiple routes of
exposure and chemical mixtures are difficult
to estimate. Individual factors that modify
exposure, such as age, race, gender, time near
the hazard, behavioral factors, and genetics,
are often not incorporated into the exposure
assessment models. Inexact exposure estimates
limit the ability to ascribe health outcomes to
a contaminant.
The lack of exposure data further compli-
cates issues because the level of exposure
influences the appropriate health end point.
At high exposure levels, health effects are
observed within a relatively short time frame
and are often documented in the scientiﬁc lit-
erature. Low-dose chronic exposures present
greater challenges: health outcomes may not
be known; effects of low-dose exposures are
not observable for years or decades; effects
may require repeated exposures over time;
multiple agents may need to interact simulta-
neously or sequentially; and the effect may
occur only in sensitive subpopulations or
those with existing health conditions. Table 1
lists additional limitations in using exposure
data for environmental public health tracking.
Health outcome data (HOD). Adverse
health events such as morbidity and mortality
are the outcomes of interest in efforts to asso-
ciate environmental hazards and exposure
with effects in humans. Of particular interest
are asthma, birth defects, cancer, and sequelae
of lead and pesticide poisoning/exposure.
Health events may be identiﬁed and evaluated
at the individual level, as is the case in tradi-
tional epidemiologic studies, or may be aggre-
gated for populations, such as those available
from local, regional, and national surveys.
The uses and limitations of population-based
aggregate data can differ from those of indi-
vidual-level data, and this affects the use of
each type of data.
EPHTN efforts focus on the use of exist-
ing (secondary) data rather than on the gen-
eration of new data (primary). Sources of
such data include local, regional, and
national health surveys such as the NHANES
and the Behavioral Risk Factor Surveillance
System, and health events and reportable dis-
ease registries such as those for cancer—the
National Cancer Institute’s (NCI) geo-
graphic information system (GIS) web site
(NCI 2004b)—and birth defects. Other
sources include state vital records, hospital
discharge data, emergency room data, and
health insurance statistics. Several potential
limitations must be considered when using
secondary HOD, including those related to
evolving or changing diagnostic criteria, mis-
classification, generalizability, measurement
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Table 1. Uses and limitations of hazard data, exposure data, and HOD.
Uses Limitations
Hazard data
Regulatory compliance  Not representative of individual exposures
Standard setting  Gaps in geographic coverage of monitors
Policymaking  High percentage of nondetected values in data
Characterization of pollution sources  Sampling and measurement errors are often unknown
Reﬂect current levels of pollutants
Insufﬁcient data quantity for trend analysis
Objectives for monitoring vary across environmental media
Exposure data
Indicator of individual exposure to a hazard Data rarely available at the individual level
Required to link hazard with health outcome Misclassiﬁcation of exposure
Difﬁcult to account for multiple exposure pathways
Exposure models based on assumptions and uncertainties
not included in statistical analysis
Lack of data amount, frequency, and duration of exposure
Variability within populations impedes generalizing exposure
Difﬁcult to reconstruct past exposure
Health outcome data
Describes health status of populations  Data completeness
Describes distribution and frequency of disease Misclassiﬁcation of disease
Generalizability to population
Conﬁdentiality issues (HIPAAa)
All three types of data
Completeness of records
Timeliness of reporting
Availability of access to data
Geographic resolution of the data (scale)
Frequency of data collection
Lack of data collection standards
aHIPAA, Health Insurance Portability and Accountability Act of 1996 (1996).error, and completeness. Secondary HOD
are also limited because many diseases/condi-
tions are not reportable, resulting in incom-
plete information for many outcomes of
interest. Further, confidentiality may pro-
hibit access to the data at the level of detail
that might be needed for correlation with an
exposure, for example, address of an individ-
ual. Table 1 lists additional limitations in
using HOD for EPHTN.
Other relevant data (covariates). The
association of a disease with a risk factor in
epidemiologic research requires more than
observing corresponding ﬂuctuations between
the two factors. For example, examining the
effect of air pollution as measured by criteria
pollutants on the incidence of asthma must
consider related factors. Other factors may
include residence, proximity to known
asthma-causing sources, socioeconomic status,
age, race, and adherence to treatment regi-
mens that may be related to incidence and
hazard/exposure. These characteristics related
to the factors of interest must also be consid-
ered and controlled. In epidemiologic
research, strict control is not feasible, in the
sense that these characteristics are not
assigned by the researcher. Instead, important
factors are observed, measured, and controlled
in the analysis. Information regarding many
of the standard covariates is routinely col-
lected and made available through the U.S.
census and surveys, including information
regarding race, age, and sex distributions, as
well as a variety of variables describing socio-
economic status, employment, and housing
statistics, among others. These data are aggre-
gated by specified units (e.g., state, county,
census tract) and have the same limitations
identified above for HOD. The decennial
census data have limitations with respect to
how current or complete the data are for a
given time period. Migration is problematic,
especially in estimating populations for small
areas. Nevertheless, these data provide
important information regarding population
characteristics necessary for establishing
denominator estimates and associating
hazard/exposure with health outcomes.
Statistical Framework
Data limitations directly affect the outcome of
statistical analyses and may at times limit the
level of analyses that might be performed with
a given data set. The lack of consistency in the
quality of geocoding in the U.S. spatial infra-
structure provides an example of such a limita-
tion. The street reference ﬁles in urban areas
may be of very good quality, whereas in rural
areas they may have limited accuracy.
Consider the impact of this varying quality on
geocoding when comparing urban and rural
areas. If unmatched cases are omitted,
urban/rural differences may be attributed to
geographic covariates rather than the
inaccuracy of geocoding. Alternatively, if
unmatched cases are allocated to the geocenter
of the spatial area, distances from a putative
exposure are still less accurate in the rural area
than in the urban area. Current statistical
methods do not account for this variability in
quality of geocoding. These limitations high-
light the need to closely examine available data
sets and determine the appropriate use of the
data as they exist and the assessment of data
quality before more complex statistical
analyses are applied. Additionally, data are col-
lected from disparate sources (e.g., U.S.
Environmental Protection Agency, CDC,
U.S. Census Bureau, state and local health and
environmental agencies) for a wide variety of
purposes (regulatory vs. surveillance). These
data sources have varying levels of quality
related to completeness, consistency of deﬁni-
tions, accuracy, and timeliness. Further, the
locations (i.e., state, county, ZIP code, census
tract, point source) of data collection can be
inconsistent or “misaligned.”
The complex relationship between
exposure and health outcome requires careful
consideration of the type of statistical model
that should be used to represent this relation-
ship. Ecologic bias is a potential problem
when hazards ascertained from data aggre-
gated over a larger geographic area are attrib-
uted to individuals within the area. It is fairly
common to see analyses in which an aggregate
measure of socioeconomic status for a ZIP
code is assigned to each individual within the
ZIP code and subsequently analyzed by meth-
ods ignoring the aggregation. The bias will
decrease with smaller geographic areas and
may be decreased by measuring confounding
variables. But all the confounders may not be
known, so whether bias has been eliminated is
generally unknown (Wakefield and Elliott
1999). In general, data containing variables
measured at individual and aggregate levels
should be analyzed by means of hierarchical
models that better describe the data and
account for the limitations of these data in
terms of the potential for ecologic bias.
Wakefield and Elliott (1999) and
Banerjee et al. (2004) review a variety of sta-
tistical methods appropriate for the analysis of
environmental and health data as well as the
health/environment relationship. These
methods attempt to realistically represent the
hazard–exposure–disease process while also
considering measurement issues. We orga-
nized these into three groups generally repre-
senting increasing complexity of study design.
The ﬁrst group is composed of descriptive
analyses and includes tracking trends (surveil-
lance), temporally and spatially, of hazard,
exposure, and HOD. These analyses provide
information on recognizing and deﬁning the
scope of a problem, describing trends,
generating baselines, and comparing changes
in temporal and spatial indices of health and
environmental data. GIS methods have been
developed for exploratory data analysis and
identiﬁcation of space–time patterns.
The second group is ecologic analysis,
which includes more advanced methods of spa-
tial analysis and involves observational studies
that provide information on the relationship
between hazards and health outcomes. These
hierarchical models can accommodate data
from several levels such as cancer registry case
point data and such regional data as poverty at
the census, block group level. Ecologic analysis
is appropriate for hypothesis generation and
provides essential information needed before
moving on to the more rigorous study designs
in group three.
Group three consists of etiologic research
using full-scale epidemiologic studies to test
hypotheses describing the relationships
between environmental exposures and a
health outcome. These studies require high-
quality, well-deﬁned data and complex statis-
tical methods that account for issues present
in the data.
Group 1:Tracking and Trend
Analysis
Time trends. Examining time trends in HOD
is helpful in identifying disease clusters. An
example is the observation of birth defects
(rare limb malformations) within a short time
among women who took thalidomide for
morning sickness. This cluster helped to iden-
tify thalidomide as a human teratogen
(Taussig 1962). Trends identified through
hazard surveillance are also important for
characterizing background and changes in
environmental contamination. Seasonal pat-
terns are also identiﬁed through surveillance,
for example, deaths from heat waves in the
summer and pneumonia and inﬂuenza deaths
in the winter season. Statistical approaches to
the detection of clusters of disease include
cell-count methods that compare observed
with expected counts of events (Knox 1964;
Openshaw et al. 1987, 1988), adjacency
methods that examine whether areas of high
rates of disease are likely to be adjacent to
other high-rate areas (Moran 1948), and dis-
tance or nearest-neighbor methods that com-
pare physical distances between cases to
expected distance (Besag and Newell 1991;
Cuzick and Edwards 1990; Mantel 1967).
Alexander and Boyle (1996) provide exten-
sions to the basic methods. Other statistical
methods can be used to determine interarrival
times between rare disease cases or to model
seasonal patterns using time series methods,
autoregression methods, and joinpoint
regression (Kim et al. 2000). These trends are
informative; however, confounding may
prohibit correct interpretation. An example is
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study was conducted to examine the prostate
cancer incidence in a plant manufacturing tri-
azine (MacLennan et al. 2002). Subsequent
investigation of prostate cancer incidence
indicated that the increase may have reﬂected
increased prostate-specific antigen (PSA)
screening rates rather than increased inci-
dence of disease.
Spatial analysis and geographic distribu-
tion. Environmental and health data have
very few commonalities; in many cases, the
only commonalities of the data are the general
geographic area and time frame. GIS is a use-
ful tool for examining each type of data and
one of the few methods that can be used to
compare disparate health and environmental
data. These include the “brush and link”
exploratory data tools such as GeoDa
(Anselin et al. 2004) and identification of
space–time patterns as available in SaTScan
software (SaTScan 2004) and the TerraSeer
Space Time Intelligence System (TerraSeer
2004). The common denominator is the
geocode for each type of data. Issues arise in
reconciling the point of sampling and the
location (and often lack of location) of indi-
viduals with the health outcome. Nonetheless,
simple mapping of each data set and overlay
of the maps can assist in targeting geographic
areas. GIS software often comes with an array
of tools to produce maps with impressive
visual displays of data, overlay of disparate
environmental and HOD, and conduct trend
analysis. Because of this, caution is necessary
to ensure that the maps are not misleading.
This can occur when health and hazard data
are mapped independently and there is con-
founding in the data that may lead the inves-
tigator to an inappropriate conclusion. For
example, the potential confounding due to
the latency period and ecologic fallacy must
be considered in interpretation. Additionally,
the residential address of a cancer case at diag-
nosis may not be a good proxy indicator for
the lifetime environmental exposure given the
mobility of the U.S. population. Geocoding
methods need to be developed that allow bet-
ter cumulative estimation of exposure that
individuals might experience during their life-
times. These should be available for regular or
irregular points in residence or occupational
histories.
Disease mapping summarizes the spatial
and temporal–spatial variation in risk. When
compared with spatial and temporal–spatial
variation in exposure/hazard, one may get
some disease etiology clues. The National
Cancer Institute’s Cancer Mortality Atlas
(NCI 2004a) and State Cancer Proﬁles (NCI
2004c) show county-specific maps that have
been instrumental in identifying cancer
disease patterns with the location of major
industries by means of ecologic studies—nasal
cancer in areas with furniture manufacturing
(Brinton et al. 1977), lung cancer in counties
with petrochemical manufacturing (Blot and
Fraumeni 1976), bladder cancer where chemi-
cal industries were located (Hoover et al.
1975), and oral cancer in regions where snuff
use was common (Blot and Fraumeni 1977).
Comparing county-level health rates from
maps requires that rates be adjusted for
potentially confounding variables such as age,
race, sex, and socioeconomic status. Elliott
et al. (2000) discuss problems in the compari-
son of indirectly adjusted rates [standard mor-
tality ratios (SMRs)] and directly adjusted
rates [comparative mortality ﬁgures (CMFs)].
CMFs may be unstable if the stratum-speciﬁc
rates are based on small numbers; however,
they are unbiased estimates of the relative risk
to the standard population. SMRs may be
biased if proportionality assumptions are not
met. Neither of these rates (SMRs, CMFs)
adjusts for the overdispersion typically found
in this type of data. Nevertheless, Breslow and
Day (1987) observe that the use of SMRs or
CMFs often leads to the same results. A
clearer exposition of which summary measure
to use would be a welcome addition to the lit-
erature. Maps of rates can be very deceptive if
they are composed of different-sized units; for
example, large units are overwhelming, and
small units are often lost in interpretation.
The microplot map (NCI 2004c) shows 95%
confidence intervals for the units, and their
intervals may overlap even though a choro-
pleth map indicates a difference. Additionally,
maps at different scales may give different
patterns, further obscuring the interpretation.
Observed rates are quite variable, especially
when the expected rates are small, so maps of
county-speciﬁc rates are smoothed by a vari-
ety of means to enhance the visualization of
regional patterns of distribution. Smoothing
methods need to consider and adjust for dif-
ferences in the population size (denominator)
for different geographic units. Methods to
compute and visualize the spatial and tempo-
ral–spatial variability in disease/mortality con-
trolling for such covariates as age, race, sex,
and deprivation are currently available, as are
extensions of the method to smooth the data
and model heterogeneity and clustering of the
area-specific effects in both the traditional
approach and Bayesian framework (Banerjee
et al. 2004; Wakeﬁeld and Elliott 1999).
These temporal, spatial, cluster, and
exploratory methods have standard software
to analyze the data. These should become
standard procedures in health departments.
Problems in interpretation will arise because
of geographic resolution of disease and envi-
ronmental data, data quality, confounding,
and ecologic bias. Replication of the analyses
in widely differing settings should provide
scientists with background information to
make the judgment as to whether to abandon
the examination of a particular health out-
come–hazard link, replicate the study, and/or
proceed to an ecologic study if significant
effects are apparent or sufficient evidence to
warrant further investigation exists (see
“Descriptive analysis” in Figure 1).
Group 2: Ecologic Analysis
Ecologic epidemiologic studies. Ecologic
studies describe the coexistence of risk factors
with disease among and within populations.
Aggregate exposure data are correlated with
aggregate health data for each unit of observa-
tion, usually deﬁned by geographic or admin-
istrative boundaries (e.g., city, county, state).
Rates of exposure and rates of disease within
each unit are known, but the exposure status
of diseased individuals is not known. Analysis
of ecologic studies can be conducted visually
by interpreting the slope of a line plot of the
exposure rate by the disease rate for each unit
or using the correlation coefficient, r, as a
measure of association. In ecologic trend
analyses, changes in rates of exposure are cor-
related with changes in rates of disease over
time. The most salient limitation of these
studies is ecologic bias, resulting from spuri-
ously ascribing aggregate-level observations to
individuals. These studies are useful for gener-
ating hypotheses, for assessing the impact of
community-level interventions, or for initial
evaluation of suspected associations, although
more rigorous studies are necessary to support
a causal relationship between exposure and
disease.
Geographic correlation studies. These
studies model the interrelationships of hazard,
exposure, and health over time and space.
The objective is to relate environmental vari-
ables to disease and control for other factors
such as life style (Banerjee et al. 2004;
Wakeﬁeld and Elliott 1999). Poisson regres-
sion provides the framework for modeling the
rates for rare diseases, whereas binomial
regression or survival analysis is suitable when
disease is more common. Counts or rates of
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Figure 1. Decision tree for statistical framework.events are described as a function of exposure,
space, time, demographics, and other vari-
ables. The models are hierarchical when haz-
ard data are used and are thus subject to
ecologic bias. Spatial correlation in the data
should be anticipated. For example, screening
for PSA is likely to be correlated among coun-
ties when the screening initiative is directed
toward a large area. Overdispersed data are an
additional problem. The methods for estimat-
ing parameters relating hazard to health out-
comes in these models are by means of
likelihood methods and by Bayesian methods.
Advantages of the likelihood methods include
the readily available software and, in some
cases, the incorporation of dispersion com-
mon in these data. Disadvantages include the
difficulty of specifying complex covariance
structures in the data, the unreliability of
SMRs based on sparse data, and the problems
of estimating variances of the relative risks.
Bayesian methods applied to the data require
the assumption of a prior distribution on
these parameters from which a posterior dis-
tribution can be used to provide point (mean,
median) and interval (95% conﬁdence inter-
vals) estimates for the parameters of interest.
These estimates are obtained by means of
Markov chain Monte Carlo methods using
WinBUGS software (MRC Biostatistics Unit,
Cambridge, UK; http://www.mrc-bsu.cam.
ac.uk/bugs/welcome.shtml). Advantages of
the Bayesian methods include the use of ran-
dom effects to represent overdispersion, the
availability of WinBUGS software for compu-
tation, and the provision of smoothed
estimates of SMRs based on sparse data.
Disadvantages of the Bayesian methods
include the sensitivity of the estimates to the
choice of the prior, and problems of conver-
gence in complicated models (Elliott et al.
2000). Wakefield and Morris (1999) extend
their analyses to accommodate spatial correla-
tion and overdispersed data in the Bayesian
analysis of the relationship between heart dis-
ease mortality and magnesium and calcium in
water. Another example using Bayesian meth-
ods is a study measuring ozone levels at
10 ﬁxed sites and emergency department vis-
its—total visits and those for asthma by ZIP
code—to assess the effect of ozone levels on
pediatric emergency department asthma vis-
its. In this example, the data for ozone and
emergency department visits are “misaligned,”
and before the data can be analyzed, a surface
(kriging) for ozone from the site data must be
developed so that an ozone level can be esti-
mated for each ZIP code. Carlin demon-
strates the use of hierarchical Bayesian models
in solving this and other misalignment prob-
lems (Banerjee et al. 2004)
Multilevel models estimating hazard and
health outcome effects and controlling for
potential confounders and covariates provide
hypothesis-generating information; however,
they will likely require more refined hazard
and disease data. Statistical methods are avail-
able but are not trivial to run and interpret,
and the potential for ecologic bias remains.
Replication of these studies in several areas
should be guided by the descriptive analyses.
Judgment of the scientiﬁc community is nec-
essary to decide whether to halt studies at this
level or, if signiﬁcant effects and consensus of
the scientific community indicate, then to
design an in-depth study (etiologic research)
(“Ecologic analyses” in Figure 1).
Group 3: Etiologic Research
Studies
Epidemiologic studies associate exposure in
individuals to health outcome by means of
case–control studies in rare diseases and by
cohort studies in groups such as in occupa-
tional settings. Hertz-Picciotto (1998) sum-
marizes a number of studies illustrating the
difﬁculties of associating environmental expo-
sure to the risk of disease, for example, the
risk of serious illness (seizures and/or death)
from drinking cider in Devonshire (Baker
1767); the risk of cholera associated with
ingestion of water contaminated by fecal mat-
ter from infected patients (Snow 1855); poor
mental development among children exposed
to lead (Needleman et al. 1979, 1990;
Needleman and Gatsonis 1990); and the
many studies on the risk of health effects asso-
ciated with air pollution (Hertz-Picciotto
1998). Statistical analysis of environmental
data when appropriate exposure measures are
of high quality is handled quite readily by
multiple logistic regression in case–control
studies and survival analysis methods such as
Cox regression.
These stronger studies requiring better
hazard/exposure and disease deﬁnition should
benefit from results of the earlier studies.
Statistical methods are available for hypo-
thesis testing of the risk associated with expo-
sure. The limitations of these studies are well
known, but the problem of identifying weak
effects in small populations remains. If the
results of these analyses show promise and, in
the opinion of scientists and policymakers, an
intervention is both possible and desirable,
then intervention studies in the form of com-
munity trials or policy decisions effecting cur-
rent or new standards should be evaluated for
impact. Intervention analyses may be imple-
mented at early stages of study, after ecologic
studies (“Etiologic analyses” in Figure 1).
Discussion
The EPHTN is developing a framework to
assess the impact of environmental agents on
human health that will begin to fill in the
“environmental health gap” described in the
Pew Environmental Health Commission
(2000) report. The environmental and health
data that reside in federal and state health and
environmental agencies hold a wealth of
information if unlocked with appropriate
linkages and analyses. The challenge is in the
details for analyzing and linking disparate
data in a scientifically sound manner while
considering appropriate data uses and limita-
tions. The magnitude of the endeavor dictates
that we carefully articulate questions that
might be reasonably answered with existing
data in the near term and set an agenda to
proceed to more complex and difficult
questions.
The Thacker et al. (1996) model should
be extended to account for exposures that
effect only a susceptible population. Further,
models speciﬁc for disease–exposure relation-
ships explaining the fate and effect of an agent
should be considered. Incorporation of policy
changes and treatment interventions should
also be considered. Guidelines on measure-
ment and acquisition of data should be pre-
pared. The Guide to Community Preventive
Services (CDC 2004) program provides a
model for how public health interventions
and treatments could be represented in
environmental situations.
The analytical framework presents groups
of analyses to facilitate a progression from
descriptive analyses to more complex linkages;
this builds the foundation for etiologic
research using epidemiologic studies.
The first group of analyses describes
spatial and temporal distribution of hazards
and outcomes independently and elucidates
trends and relationships that can be further
explored. These descriptive methods provide
basic information to agencies and policy-
makers and suggestions for further studies.
The second group of analyses focuses on eco-
logic studies that associate hazard with health
outcomes using recently developed methods
such as GIS spatial analysis, hierarchical mod-
els, and Bayesian methods. These methods
address environmental and disease measure-
ment issues, and experience with their use will
generate hypotheses and a core set of analyses
that may become the standard methods for
linking health and environmental data. The
third group relates exposure to outcome using
traditional epidemiologic study designs to test
hypotheses. These are research studies that
should build on preceding descriptive and
ecologic analyses.
The framework for analyses highlights the
necessity for collaborations and partnerships.
Data sharing is essential to EPHTN and
requires overcoming the organizational and
functional problems limiting collaboration
between health and environmental agencies.
Further, multidisciplinary teams with expertise
in epidemiology, statistics, toxicology, envi-
ronmental health, database management,
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GIS, and other areas will be required to
ensure sound science and appropriate analysis
of data. The EPHTN has established academic/
agency partnership and designated Centers of
Excellence to serve as a resource to state
health agencies. As more complex linkages
and analyses are conducted, greater statistical
expertise will be needed in this initiative.
Conclusions
The linkage of two or more types of data pro-
vides a powerful tool, but only if the steps in
Thacker et al. (1996) “hazard-exposure-out-
come” model are considered. The lack of
exposure data is an impediment to more com-
plex linkages. In the descriptive analyses, the
lack of exposure data may be acceptable, but
studies of more complex linkages will require
more and better data. Additional efforts to
generate exposure data, perhaps in partner-
ship with public health laboratories, need to
be formulated.
Statistical methods are available to link
hazards and covariates to health outcomes;
however, the appropriate uses and limitations
of each data set must be taken into account.
The analysis of hazard data and their linkage
to health outcomes are subject to ecologic
bias; use of smaller geographical area may
minimize that bias. Newer methods such as
GIS spatial analysis, hierarchical models, and
Bayesian methods are promising but require
experience and repeated use with various
types of linkages before they become standard
techniques. If used properly, statistical meth-
ods are available to begin analyses and linkage
of environmental hazard, exposure, and
health data that in turn will provide informa-
tion to the public, policymakers, and the
scientiﬁc community.
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